PPT-Efficacy and safety of switching from boosted-protease inhibitors plus
Author : calandra-battersby | Published Date : 2018-12-24
emtricitabine tenofovir disoproxil fumarate regimens to the singletablet regimen STR of darunavir cobicistat emtricitabine tenofovir alafenamide DCFTAF in
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Efficacy and safety of switching from bo..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Efficacy and safety of switching from boosted-protease inhibitors plus: Transcript
emtricitabine tenofovir disoproxil fumarate regimens to the singletablet regimen STR of darunavir cobicistat emtricitabine tenofovir alafenamide DCFTAF in virologically. The 100X Protease Inhibitor Cocktail is a clear colorless liquid Background In order to study speci64257c target proteins of interest proteasemediated degradation during the genera tion of protein lysates is to be avoided A loss of normal cellular c Mark Sulkowski, MD. Associate Professor of Medicine . Johns Hopkins University School of Medicine . Limitations of PegIFN + Ribavirin . (with or without protease inhibitors). Antiviral activity is host + virus genotype dependent . Stereochemistry. Many biomolecules, including proteins, carbohydrates and DNA, are chiral. . A typical drug molecule acts by docking with a target biomolecule such as an enzyme or receptor. These drugs are often chiral, and the two enantiomers may differ greatly in efficacy.. 1. 1. http://www.accessdata.fda.gov/cdrh_docs/pdf/P980048b.pdf. The . views and opinions expressed in the following PowerPoint slides are those of . the individual . presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, . Stereochemistry. Many biomolecules, including proteins, carbohydrates and DNA, are chiral. . A typical drug molecule acts by docking with a target biomolecule such as an enzyme or receptor. These drugs are often chiral, and the two enantiomers may differ greatly in efficacy.. One sneeze can generate an aerosol of enough cold viruses to infect thousands of people!. Treatment of . Herpesviruses. . Varicella-zoster,. Cytomegalavirus,. Herpes simplex. Anti-metabolites . . “False” DNA building blocks . Ominous Octet. Renal Handling of Glucose. Active (SGLT2) and Passive (GLUT2) Glucose Transport in a Renal Proximal Tubule Cell. Renal Glucose Transport . GLUTs . Altered Renal Glucose Control . in T2D. Shaw Vonder Hoya. Worldwide Prevalence. Types of HIV. HIV type 1:. Most common. Originated from chimpanzee SIV. High infectivity and virulence. HIV type 2:. Mostly confined to West Africa. Came from sooty . Learning Objectives. EARLY VS DEFERRED ART. The Case is Made. Should Early-Stage Asymptomatic HIV Patients Receive ART? . The INSIGHT START Study. The CD4 Cell Count As a Measure . of Immune Deficiency in HIV Patients. Program Overview . Discussion Outline. DNA Repair. ABCs of DNA Repair. DNA Repair Defects in Cancer. DNA Repair Defects Can Be an Achilles' Heel. Synthetic Lethality and Cancer DNA Repair Defects. Increased Sensitivity of . and . Immunogenicity. Peyman Eshghi. Prof. of Pediatric Hematology &Oncology. Pediatric Congenital Hematologic Disorders Research Center. Mofid. Children Hospital. Shahid Beheshti University of Medical sciences. double-blind, placebo-controlled study with open-label extension. Atul Deodhar, MD. Oregon Health & Science University. Portland, OR, USA. Key message. Upadacitinib – a JAK1 inhibitor – showed sustained and consistent efficacy over 1 year in AS patients.. DEPARTMENT OF CHEMISTRY. D.D.U. GORAKHPUR UNIVERSITY. GORAKHPUR. ACKNOWLEDGEMENT. I bow before the . electic,divine. and blessing forces (parents and teachers).. Who made me worthy of doing this scared job to completion.. Dr.Abdul. . latif Mahesar. How . HIVpositive. . differs from AIDS. Does in every case HIV leads to AIDS ?. HIV . causes . AIDS: This is a progressive failure of immune system which allows life threatening infections and .
Download Document
Here is the link to download the presentation.
"Efficacy and safety of switching from boosted-protease inhibitors plus"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents